iNeo-Vac-T01

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameiNeo-Vac-T01
Drug Alias NameiNeo-VacTM-T01iNeo-VacTM-T01 (个体化肿瘤新生抗原特异性自体免疫细胞产品)
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsColorectal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Neoantigen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Neoantigen Therapeutics
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A